Anna Schoenbach,  —

Recent Posts

• Study links gut bacteria to severity of scleroderma-related ILD
• New study finds sexual dysfunction is common in scleroderma
• EBV infections may affect risk of developing scleroderma: Analysis
• Clumps of modified stem cells seen to ease skin, lung scarring in mice
• Efzofitimod found safe, well tolerated in study of SSc-ILD
• Study shows immune signaling protein IL-40 is also involved in SSc
• First SSc patient dosed in Phase 1 trial of CAR T-cell therapy
• National Scleroderma Foundation recognizes outstanding chapters
• Developing a plan is helpful when dealing with medical uncertainty
• SRF joins capital effort to advance drug development for scleroderma